TrialJournal of the National Cancer Institute2025

Predicting ovarian function loss after chemotherapy and anti-HER2 therapy in young breast cancer patients.

Matteo Lambertini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.